Diabetology
Assessing the Impact of Sitagliptin and Glimepiride Combination Therapy on Glycemic Control - Survey Report
Exploring Healthcare Provider Practices and Opinions regarding Lobeglitazone in Type 2 Diabetes Therapy - Survey Report
Perception Mapping of Indian Physicians on Efficacy and Safety of Sitagliptin + Glimepiride + Metformin in T2DM Management_Report
Survey Closure Report - Perception Mapping of Indian Physicians on Efficacy and Safety of Sitagliptin + Glimepiride + Metformin in T2DM Management
ReportSurvey Closure Report - Perception Mapping of Physicians on Therapeutic Usage of Dapagliflozin in Indian Patients with Type 2 Diabetes Mellitus in Real-life Scenario
ReportSurvey Report -Evaluate the Effectiveness of Combination of Linagliptin 5mg with Metformin 1000mg
Survey Report- Therapeutic Usage of Vildagliptin + Dapagliflozin Combination in Current Clinical Scenario in India
Therapeutic usage of Vildagliptin + Dapagliflozin + Metformin Combination in Indian Patients with Diabetes Mellitus CCS
Effectiveness of Combination of Linagliptin with Dapagliflozin & as a triple combination of Linagliptin + Dapagliflozin + Metformin
Potential Role of Combination Therapy with Sitagliptin, Metformin and Pioglitazone in Diabetes Management in Current Clinical Scenario
ReportPotential Role of Triple Combination of Sitagliptin + Glimepiride + Metformin in Diabetes Management in CE